← All companies

EWTX

Edgewise Therapeutics, Inc.

EWTX Nasdaq Pharmaceutical Preparations EDGAR ↗

$38.38

-2.74 -6.66%

Key statistics

from XBRL data in SEC filings

Market cap

$4.13B

Revenue (TTM)

—

Net income (TTM)

-$8.38M

EPS (TTM)

$-1.66

P/E ratio

—

Dividend yield

—

Free cash flow

-$144M

Cash

$33.2M

Total assets

$519M

Gross margin

—

52-week range

$12.30 – $48.40

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K/A FORM 8-K/A Jul 16, 2026 8-K Completed an acquisition or disposition; Regulation FD disclosure Jul 13, 2026 8-K Shareholder vote results Jun 5, 2026 8-K Entered a material agreement Jun 1, 2026 8-K Results of operations (earnings release) May 7, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 10-K Fiscal year ended 2025-12-31 Feb 26, 2026 8-K Results of operations (earnings release) Feb 26, 2026 8-K Director or officer change Nov 20, 2025 8-K Director or officer change; Regulation FD disclosure Nov 10, 2025 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release) Nov 6, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Results of operations (earnings release) Aug 7, 2025 8-K Regulation FD disclosure; Other events Jun 26, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Results of operations (earnings release) May 8, 2025 8-K Entered a material agreement; Regulation FD disclosure Apr 2, 2025 8-K Regulation FD disclosure; Other events Apr 2, 2025 10-K Fiscal year ended 2024-12-31 Mar 3, 2025 8-K Results of operations (earnings release) Mar 3, 2025 8-K Director or officer change Jan 22, 2025 8-K Regulation FD disclosure; Other events Dec 16, 2024 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Results of operations (earnings release) Nov 7, 2024 8-K Director or officer change Aug 12, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Results of operations (earnings release) Aug 8, 2024 8-K Amended charter or bylaws; Shareholder vote results Jun 11, 2024 8-K Entered a material agreement; Terminated a material agreement May 10, 2024 10-Q Quarter ended 2024-03-31 May 9, 2024 8-K Results of operations (earnings release) May 9, 2024 8-K Director or officer change May 7, 2024 10-K Fiscal year ended 2023-12-31 Feb 22, 2024 8-K Results of operations (earnings release) Feb 22, 2024 8-K Entered a material agreement; Regulation FD disclosure Jan 19, 2024 8-K Results of operations (earnings release); Other events Jan 19, 2024 10-Q Quarter ended 2023-09-30 Nov 9, 2023 8-K Results of operations (earnings release) Nov 9, 2023 10-Q Quarter ended 2023-06-30 Aug 10, 2023